ATE387209T1 - Oral einnehmbare zubereitung von mistellectinen und verfahren - Google Patents

Oral einnehmbare zubereitung von mistellectinen und verfahren

Info

Publication number
ATE387209T1
ATE387209T1 AT01996387T AT01996387T ATE387209T1 AT E387209 T1 ATE387209 T1 AT E387209T1 AT 01996387 T AT01996387 T AT 01996387T AT 01996387 T AT01996387 T AT 01996387T AT E387209 T1 ATE387209 T1 AT E387209T1
Authority
AT
Austria
Prior art keywords
preparation
mistle
ectins
mistletoe
iii
Prior art date
Application number
AT01996387T
Other languages
English (en)
Inventor
Ian Pryme
Original Assignee
Ian Pryme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ian Pryme filed Critical Ian Pryme
Application granted granted Critical
Publication of ATE387209T1 publication Critical patent/ATE387209T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01996387T 2000-11-14 2001-11-12 Oral einnehmbare zubereitung von mistellectinen und verfahren ATE387209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24795700P 2000-11-14 2000-11-14

Publications (1)

Publication Number Publication Date
ATE387209T1 true ATE387209T1 (de) 2008-03-15

Family

ID=22937047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996387T ATE387209T1 (de) 2000-11-14 2001-11-12 Oral einnehmbare zubereitung von mistellectinen und verfahren

Country Status (13)

Country Link
US (1) US7550159B2 (de)
EP (1) EP1341811B9 (de)
JP (1) JP2004513926A (de)
KR (1) KR100832614B1 (de)
AT (1) ATE387209T1 (de)
AU (1) AU2120502A (de)
CY (1) CY1107965T1 (de)
DE (1) DE60133036T2 (de)
DK (1) DK1341811T3 (de)
ES (1) ES2301576T3 (de)
NZ (1) NZ526202A (de)
PT (1) PT1341811E (de)
WO (1) WO2002040041A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418800B1 (de) 2001-07-09 2007-05-09 University of Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
KR101191081B1 (ko) 2008-05-19 2012-10-15 김종배 운동수행능력 증강 및 피로억제 효과를 갖는 겨우살이추출물
RU2644332C1 (ru) * 2016-12-30 2018-02-08 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ получения растительного лектина ml1 из омелы белой и фармацевтическая композиция на его основе (варианты).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229876A1 (de) * 1992-09-04 1994-03-10 Uwe Dr Pfueller Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen
DE4242902A1 (de) * 1992-12-18 1994-06-23 Madaus Ag Verfahren zur Herstellung von Lektinkonzentraten aus Mistelextrakten und daraus hergestellte standardisierte Präparate zur Erhöhung der natürlichen Immunresistenz und für die Verwendung in der Tumor-Therapie
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
DE4421895A1 (de) * 1994-06-23 1996-01-04 Private Uni Witten Herdecke Gm Verfahren zur Isolierung von Isolektinen aus der Mistel
EP0824355A4 (de) * 1995-04-14 1998-12-30 Univ Southern California Mistelextrakt und verfahren zu seiner verwendung
EP0751221B1 (de) * 1995-06-26 1998-09-09 MADAUS AG Köln Rekombinantes Mistellektin (rML)
WO1997011967A1 (de) * 1995-09-27 1997-04-03 Thomas David Extrakt von viscum album (weisse mistel)
CA2389080C (en) * 1999-10-26 2012-02-21 Chiron Corporation Mistletoe lectins as mucosal adjuvants

Also Published As

Publication number Publication date
KR20030066664A (ko) 2003-08-09
US20040052869A1 (en) 2004-03-18
DK1341811T3 (da) 2008-06-30
NZ526202A (en) 2005-08-26
PT1341811E (pt) 2008-06-04
DE60133036D1 (de) 2008-04-10
KR100832614B1 (ko) 2008-05-27
WO2002040041A2 (en) 2002-05-23
EP1341811A2 (de) 2003-09-10
US7550159B2 (en) 2009-06-23
CY1107965T1 (el) 2013-09-04
EP1341811B9 (de) 2008-11-05
WO2002040041A3 (en) 2002-07-25
EP1341811B1 (de) 2008-02-27
AU2120502A (en) 2002-05-27
DE60133036T2 (de) 2009-04-02
ES2301576T3 (es) 2008-07-01
JP2004513926A (ja) 2004-05-13

Similar Documents

Publication Publication Date Title
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
DK1509521T3 (da) 1H-Imidazol[4,5-c]quinolinderivater til behandling af proteinkinaseafhænige sygdomme
BRPI0513959A (pt) anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
DE60222264D1 (en) Phenylpyrazolderivate als seh-inhibitoren
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
UY27273A1 (es) Solución oral de arilpiprazol
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
MXPA04000599A (es) Derivados del acido indan acetico y su uso como agentes pharmaceuticos, intermediarios, y metodo de preparacion.
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
WO2002067771A3 (en) Chemokine receptors and disease
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
DE60133036D1 (de) Oral einnehmbare zubereitung von mistellectinen und verfahren
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
DE60233936D1 (de) Therapeutische Zusammenseztungen zur Toleranzinduktion
DE60226126D1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
DE602004007491D1 (de) Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin
ATE360431T1 (de) Saururus chinensis-extrakt zur prophylaxis und behandlung neurodegenerativer krankheiten
ZA200300675B (en) Pharmaceutical preparation of the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma.
WO2002026258A3 (en) Treatment of immune-mediated diseases by oral administration of plasma fractions
IL162857A (en) Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases
UA34283A (uk) Спосіб діагностики порушень імунологічного статусу у людини та тварин

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1341811

Country of ref document: EP